Quoin Pharmaceuticals announced the publication of a peer-reviewed paper detailing the use of QRX003, an investigational topical lotion, in treating Netherton Syndrome, a rare genetic skin disorder. The case report highlights a pediatric patient who showed significant skin improvement and elimination of itching after 21 months of compassionate use treatment with QRX003, with no adverse effects reported. The company is conducting a Phase 2/3 clinical trial expected to complete recruitment by the end of 2026, with topline data anticipated in Q2 2027. This publication supports QRX003's potential as a new treatment option for this underserved condition.
Quoin Pharmaceuticals' recent peer-reviewed publication on QRX003 for Netherton Syndrome provides context for readers following health innovations. For readers following health sector stocks, here is Pluang's market snapshot as of Oct 20, 2026 17:01 WIB: of 150 priced Health-sector US stocks tradable on Pluang, 78 rose and 62 fell today. Notable movers include SNY (Sanofi SA) at USD 40.49 with a 1-day change of +2.32% and a typical hold time on Pluang of 95 days, BKD (Brookdale Senior Living Inc.) at USD 10.08 with a +2.23% change and an 11-day hold time for ELAN (Elanco Animal Health) at USD 22.99 with a -2.13% change.
The global flue gas desulfurization (FGD) system market is expected to increase from $23.6 billion in 2026 to $31.7 billion by 2031, driven by stricter sulfur dioxide emission regulations and ongoing coal power use in developing countries. Growth is ...
The global API 6D ball valve market is projected to grow from $1.20 billion in 2025 to $1.61 billion by 2031, at a 5% compound annual growth rate. Growth is fueled by investments in oil and gas infrastructure, LNG capacity, and refining operations. N...
The global single cell sequencing market is projected to grow at a 15% CAGR through 2035, reaching an estimated value of $1.38 billion in 2026. Growth is fueled by advances in genomics, reduced sequencing costs, and increased use in drug discovery, d...
VINCI's subsidiary Cobra IS secured a €165 million contract to build the cooling system for a massive data center campus in the Iberian Peninsula. The project includes installing mechanical, electrical, and plumbing equipment for 126 air cooling unit...
VINCI's subsidiary Cobra IS secured a €165 million contract to construct a cooling plant for a major data center campus in the Iberian Peninsula. The project involves installing mechanical, electrical, and plumbing systems for 126 dry coolers, which ...
